Serveur d'exploration MERS - Checkpoint (Istex)

Index « Titre (en) » - entrée « transfusion »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
transforming < transfusion < transfusions  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000146 (2015) S. L. Stramer [États-Unis] ; R. Y. Dodd [États-Unis] ; C. Y. Chiu [États-Unis]Advances in testing technology to ensure transfusion safety – NAT and beyond
000200 (2014) S. L. Stramer [États-Unis]Current perspectives in transfusion‐transmitted infectious diseases: emerging and re‐emerging infections
000232 (2013) Susan L. Stramer ; Roger Y. DoddTransfusion‐transmitted emerging infectious diseases: 30 years of challenges and progress
000437 (2011) J. L. Callum [Canada] ; Y. Lin [Canada] ; A. Lima [Canada] ; L. Merkley [Canada]Transitioning from ‘blood’ safety to ‘transfusion’ safety: addressing the single biggest risk of transfusion
000930 (2007) Abstracts for the Joint Conference of the Canadian Society for Transfusion Medicine, Canadian Blood Services and Héma‐Québec, Calgary, Alberta, Canada, May 4–6, 2007
000A76 (2005) Jay P. Brooks [États-Unis]Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products
000B03 (2005) M. A. Siegenthaler [Suisse] ; P. Schneider [Suisse] ; D. Vu [Suisse] ; J. Tissot [Suisse]Haemovigilance in a general university hospital: need for a more comprehensive classification and a codification of transfusion‐related events
000B37 (2005) Abstracts of the Joint Conference of the Canadian Society for Transfusion Medicine, Canadian Blood Services and Héma‐Québec, Banff, Alberta, Canada, 21–24 April 2005
001690 (1996) F. C. Chao ; B. K. Kim ; A. M. Houranieh [États-Unis] ; F. H. Liang ; M. W. Konrad ; S. N. Swisher ; J. L. TullisInfusible platelet membrane microvesicles: a potential transfusion substitute for platelets
001D04 (1993) S-J. Hwang [République populaire de Chine] ; S-D. Lee [République populaire de Chine] ; Y-H. W. Lee [République populaire de Chine] ; J-C. Wu [République populaire de Chine] ; C-Y. Chan [République populaire de Chine] ; Y-S. Huang [République populaire de Chine] ; Y-J. Wang [République populaire de Chine] ; K-J. Lo [République populaire de Chine]A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "transfusion" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "transfusion" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    transfusion
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021